Rocklatan From Aerie Pharmaceuticals, Inc
August 15th 2019The FDA has approved Rocklatan (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%, from Aerie Pharmaceuticals, Inc, for the reduction of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
Stay on Top of Vaccine Recommendations to Counsel Patients
August 7th 2019https://pharmacytimes.com/peer-exchange/the-progression-of-immunization-At its meeting in June, the ACIP made some very interesting suggestions, noting that all children and adolescents between ages 2 and 18 who have not previously received the hepatitis A vaccine should receive a catch-up vaccination and encouraging a change in the human papillomavirus vaccination guidelines to cover men up to age 26.